Search
for
Sort by
Research 31–60 of 563
- Evaluation of risk of SSRI-associated impotence and low libido in men exposed to finasteride
- Approaching Erectile Dysfunction in Dermatology Patients
- Adverse effects of common medications on male fertility
- Trends in the Development of New Drugs for Treatment of Benign Prostatic Hyperplasia
- Alopesi Tedavisinde Kullanılan İlaç Tedavileri ve Yeni Yaklaşımlar
- Monovalent antibody-conjugated lipid-polymer nanohybrids for active targeting to desmoglein 3 of keratinocytes to attenuate psoriasiform inflammation
- The pharmacological treatment of alopecia areata
- 22-Year-Old Male with Several Discrete Patches of Hair Loss
- Alopecia areata
- Alopecia areata: from pathophysiology to therapeutic innovation
- Lack of efficacy of apremilast in 9 patients with severe alopecia areata
- Apremilast is efficacious in refractory alopecia areata
- Non-FDA-Approved Uses of Apremilast in Dermatology: A Review of Current Available literature
- 1113 Targeting anti-inflammatory immunonanocarriers to human and murine neutrophils via Ly6 antigen for psoriasiform dermatitis alleviation
- The urologic impact of long-term finasteride 1-mg use for androgenic alopecia: a matched-cohort database analysis
- PD49-03 IS TADALAFIL ASSOCIATED WITH DECREASED RISK OF MAJOR ADVERSE CARDIAC EVENTS OR VENOUS THROMBOEMBOLISM IN MEN WITH LOWER URINARY TRACT SYMPTOMS?
- Referee report. For: Recent advances in treatment for Benign Prostatic Hyperplasia [version 1; referees: 2 approved]
- Cytokine Targeted Therapeutics for Alopecia Areata: Lessons from Atopic Dermatitis and Other Inflammatory Skin Diseases
- INTERACTION OF α-MELANOCYTE-STIMULATING HORMONE, MELATONIN, CYCLIC AMP AND CYCLIC GMP IN THE CONTROL OF MELANOGENESIS IN HAIR FOLLICLE MELANOCYTES IN VITRO
- The ‘bald’ phenotype (androgenetic alopecia) is caused by the high glycaemic, high cholesterol and low mineral ‘western diet’
- Persistent Sexual Dysfunction with Finasteride 1 mg Taken for Hair Loss
- 873 The effect of Cilostazol on hair growth: A novel therapeutic option for the treatment of hair loss
- PD49-02 MEDICATIONS MOST COMMONLY ASSOCIATED WITH ERECTILE DYSFUNCTION: EVALUATION OF THE FOOD AND DRUG ADMINISTRATION NATIONAL PHARMACOVIGILANCE DATABASE
- Caffeine’s Mechanisms of Action and Its Cosmetic Use
- When two plus two must not equal four
- From bench to babies – drug development for male subfertility
- Apremilast for extensive and treatment-resistant alopecia areata: a retrospective analysis of five patients
- ENZYMES
- Lower Urinary Tract Symptoms in Men
- Lower Urinary Tract Symptoms: What’s New in Medical Treatment?